Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Sep/25/2020 Oct/19/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Pyronaridine Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020 Oct/04/2020 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/29/2020 0
BNT162b1 Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020 Aug/26/2020 0
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6′-O-acetyl)-β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranoside Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020 Aug/26/2020 0
Torososide B Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020 Aug/26/2020 0
Theaflavin gallate Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020 Aug/26/2020 0